Eleven Biotherapeutics reported $169.79M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Amgen AMGN:US $ 6528M 1461M
Bayer BAYN:GR € 5785M 1221M
Bristol Myers Squibb BMY:US $ 12369M 1610M
Corcept Therapeutics CORT:US $ 61.86M 15.76M
Eleven Biotherapeutics EBIO:US $ 169.79M 7.15M
Eli Lilly And LLY:US $ 2459.2M 1359.3M
Intrexon XON:US $ 40.32M 2.6M
Merk MRK:US $ 8556M 460M
Pfizer PFE:US $ 2470M 526M
Rigel Pharmaceuticals RIGL:US $ 24.68M 5.79M
Ziopharm Oncology ZIOP:US $ 68.26M 7.8M